Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: A multicenter study

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Kamada, Tomoari ^a   Sato, Motonori ^b   Tokutomi, Tadashi ^c   Watanabe, Tetsuo ^d   Murao, Takahisa ^a   Matsumoto, Hiroshi ^a   Manabe, Noriaki ^a   Ito, Masanori ^e   Tanaka, Shinji ^f   Inoue, Kazuhiko ^a   Shiotani, Akiko ^a   Akiyama, Takashi ^a   Hata, Jiro ^a   Haruma, Ken ^a   Bernardo, David ^g  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b Sato Hospital   (Japan)

^c Tokutomi Medical Clinic   (Japan)

^d Department of Surgery   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

^f HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^g Department of Endoscopy Hiroshima University Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; GASTRIN; OMEPRAZOLE; PEPSINOGEN; REBAMIPIDE; ALANINE; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CLEARANCE; CHRONIC GASTRITIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTRIN BLOOD LEVEL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; GASTRITIS; HELICOBACTER INFECTIONS; INFLAMMATION; MIDDLE AGED; PATHOLOGY; STOMACH; VERY ELDERLY;

HELICOBACTER PYLORI;

ADULT; AGED; AGED, 80 AND OVER; ALANINE; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; QUINOLONES; STOMACH;

EID: 84929346557     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/865146     Document Type: Article

References (33)

1. T.Marugame, T. Matsuda, K.-I. Kamo, K. Katanoda, W. Ajiki, and T. Sobue, "Cancer Incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries, " Japanese Journal of Clinical Oncology, vol. 37, no. 11, pp. 884-891, 2007.
2. J. R.Warren and B. J. Marshall, "Unidentified curved bacilli on gastric epithelium in active chronic gastritis, " The Lancet, vol. 321, no. 8336, pp. 1273-1275, 1983.
3. J. Q. Huang, S. Sridhar, Y. Chen, andR. H. Hunt, "Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer, " Gastroenterology, vol. 114, no. 6, pp. 1169-1179, 1998.
4. A. Nomura, G. N. Stemmermann, P.-H. Chyou, I. Kato, G. I. Perez-Perez, and M. J. Blaser, "Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii, " The New England Journal ofMedicine, vol. 325, no. 16, pp. 1132-1136, 1991.
5. J. Parsonnet, G. D. Friedman, D. P. Vandersteen et al., "Helicobacter pylori infection and the risk of gastric carcinoma, " The New England Journal of Medicine, vol. 325, no. 16, pp. 1127-1131, 1991.
6. N. Uemura, S. Okamoto, S. Yamamoto et al., "Helicobacter pylori infection and the development of gastric cancer, "TheNew England Journal of Medicine, vol. 345, no. 11, pp. 784-789, 2001.
7. IARCWorking Group on the Evaluation of Carcinogenic Risks to Humans, "Schistosomes, liver flukes and Helicobacter pylori, " in IARCMonographs on the Evaluation of Carcinogenic Risks to Humans, vol. 61, pp. 1-241, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon, France, 1994.
8. IARCWorking Group on the Evaluation of Carcinogenic Risks to Humans, "Biological agents. Volume 100 B. A review of human carcinogens, " IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 100, part B, pp. 1-441, 2012.
9. K. Fukase, M. Kato, S. Kikuchi et al., "Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial, " The Lancet, vol. 372, no. 9636, pp. 392-397, 2008.
10. M. Asaka, M. Kato, S.-I. Takahashi et al., "Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition, " Helicobacter, vol. 15, no. 1, pp. 1-20, 2010.
11. T. Kamada, J. Hata, K. Sugiu et al., "Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan, " Alimentary Pharmacology and Therapeutics, vol. 21, no. 9, pp. 1121-1126, 2005.
12. A. Shiotani, N. Uedo, H. Iishi et al., "Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia, " International Journal of Cancer, vol. 121, no. 6, pp. 1182-1189, 2007.
13. A. Shiotani, N. Uedo, H. Iishi et al., "Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication, " Digestion, vol. 78, no. 2-3, pp. 113-119, 2008.
14. K. Higuchi, T. Takeuchi, N. Uedo et al., "Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study, " Gastric Cancer, vol. 7, no. 8, 2014.
15. M. Takayama, S.Matsui, M. Kawasaki et al., "Efficacy of treatment with rebamipide for endoscopic submucosal dissectioninduced ulcers, " World Journal of Gastroenterology, vol. 19, no. 34, pp. 5706-5712, 2013.
16. K. H. Song, Y. C. Lee, D.-M. Fan et al., "Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study, " Digestion, vol. 84, no. 3, pp. 221-229, 2011.
17. K. Haruma, M. Ito, S. Kido et al., "Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis, " Digestive Diseases and Sciences, vol. 47, no. 4, pp. 862-867, 2002.
18. X.Chen, K.Haruma, T.Kamada et al., "Factors that affect results of the 13C urea breath test in Japanese patients, " Helicobacter, vol. 5, no. 2, pp. 98-103, 2000.
19. M. F. Dixon, R. M. Genta, J. H. Yardley, and P. Correa, "Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994, "The American Journal of Surgical Pathology, vol. 20, no. 10, pp. 1161-1181, 1996.
20. M. Kusano, Y. Shimoyama, S. Sugimoto et al., "Development and evaluation of FSSG: frequency scale for the symptoms of GERD, " Journal of Gastroenterology, vol. 39, no. 9, pp. 888-891, 2004.
21. M. Kusano, H. Hosaka, A. Kawada et al., "Development and evaluation of a modified Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease to distinguish functional dyspepsia from non-erosive reflux disease, " Journal of Gastroenterology and Hepatology, vol. 27, no. 7, pp. 1187-1191, 2012.
22. M. Hongo, H. Miwa, M. Kusano, and J-FAST Group, "Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors, " Journal of Gastroenterology and Hepatology, vol. 27, no. 5, pp. 913-918, 2012.
23. M. Yoshihara, K. Sumii, K. Haruma et al., "Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects, " American Journal of Gastroenterology, vol. 93, no. 7, pp. 1090-1096, 1998.
24. K. Miki, M. Morita, M. Sasajima, R. Hoshina, E. Kanda, and Y.Urita, "Usefulness of gastric cancer screening using the serum pepsinogen test method, " The American Journal of Gastroenterology, vol. 98, no. 4, pp. 735-739, 2003.
25. K. Kiyohira, M. Yoshihara, M. Ito, K. Haruma, S. Tanaka, and K. Chayama, "Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels, " Journal of Gastroenterology, vol. 38, no. 4, pp. 332-338, 2003.
26. A. Sugiyama, F. Maruta, T. Ikeno et al., "Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil, " Cancer Research, vol. 58, no. 10, pp. 2067-2069, 1998.
27. T.Watanabe, M. Tada, H.Nagi, S. Sasaki, andM. Nakao, "Helicobacter pylori infection induces gastric cancer in Mongolian gerbils, " Gastroenterology, vol. 115, no. 3, pp. 642-648, 1998.
28. M. Kodama, K. Murakami, T. Okimoto et al., "Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication, " Journal of Gastroenterology, vol. 47, no. 4, pp. 394-403, 2012.
29. A. Kleine, S. Kluge, and B. M. Peskar, "Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats, " Digestive Diseases and Sciences, vol. 38, no. 8, pp. 1441-1449, 1993.
30. Y. Naito, T. Yoshikawa, T. Tanigawa et al., "Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study, " Free Radical Biology and Medicine, vol. 18, no. 1, pp. 117-123, 1995.
31. P.Moayyedi, J. Deeks, N. J. Talley, B. Delaney, and D. Forman, "An update of the Cochrane systematic review of Helicobacter pylori radication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews, " The American Journal of Gastroenterology, vol. 98, no. 12, pp. 2621-2626, 2003.
32. P.Moayyedi, S. Soo, J. Deeks et al., "Eradication of Helicobacter pylori for non-ulcer dyspepsia, " Cochrane Database of Systematic Reviews, vol. 25, no. 1, Article IDCD002096, 2005.
33. B. Zhao, J. Zhao, W.-F. Cheng et al., "Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a metaanalysis of randomized controlled studies with 12-month follow-up, " Journal of Clinical Gastroenterology, vol. 48, no. 3, pp. 241-247, 2014.